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Age may affect coronary flow reserve (CFR) especially in subjects with atherosclerotic risk factors (ARFs). The aim of
this prospective, multicenter, observational study was to determine the effects of aging on CFR in patients with
normal epicardial coronary arteries and ARFs. Three-hundred-thirty-five subjects (mean age = 61 years) with at least
one ARF but normal coronary angiography underwent high-dose dipyridamole stress-echo with Doppler evaluation
of left anterior descending artery. CFR was calculated as the ratio between hyperemic and resting coronary diastolic
peak velocities. Patients were divided in age quartiles. CFR was progressively reduced with aging (1st quartile:
3.01 ± 0.69, 4th quartile: 2.39 ± 0.49, p< 0.001). This was mainly due to a gradual increase of resting velocities
(1st quartile = 26.3 ± 6.1 cm/s, 4th quartile = 30.2 ± 6.4 cm/s, p< 0.001) while the reduction of hyperemic velocities
remained unaffected (1st quartile = 77.7 ± 18.9 cm/s, 4th quartile = 70.9 ± 18.4 cm/s, NS). When age quartiles and ARFs
were entered into a regression model, third and fourth age quartile (p< 0.0005 and p< 0.0001 respectively), left
ventricular mass index (p< 0.0001), diastolic blood pressure (p< 0.001), total cholesterol (p< 0.002), fasting blood
glucose (p< 0.01) and male gender (p< 0.05) were independent determinants of CFR in the whole population.
Aging reduces coronary flow reserve in patients with angiographically normal coronary arteries due to a gradual
increase of resting coronary flow velocity. CFR is also affected by atherosclerotic risk factors and left
ventricular hypertrophy.
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Stress echocardiography.Introduction
Coronary flow reserve (CFR) represents the maximal in-
crease in coronary flow above its resting level for a given
perfusion pressure when coronary vasculature is max-
imally dilated [1,2]. Conceptually, CFR is the difference
between the basal, autoregulated coronary flow and the
maximal flow, at any given perfusion pressure [3,4]. In
the clinical setting, however, CFR is measured in dimen-
sionless units by dividing maximal by autoregulated
flow, that is the CFR ratio.* Correspondence: mgalderi@unina.it
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reproduction in any medium, provided the orCFR can be measured by several - invasive or non in-
vasive - techniques, which quantify coronary blood flow
in absolute terms (e.g., positron emission tomography
[PET]) or measure coronary blood flow velocity (Dop-
pler) and calculate coronary flow velocity reserve [5].
Among these techniques, transthoracic echocardiog-
raphy (TTE) allows the recording of flow velocities with
a high feasibility for the mid-distal left anterior descend-
ing artery (LAD) [6]. TTE derived CFR of LAD has an
excellent concordance with invasive Doppler flow wire
and optimal reproducibility [6,7] and has now entered
the stress echo laboratory for its clinical routine use dur-
ing vasodilator stress testing.
A reduction in coronary flow reserve can be associated
to a significant epicardial coronary artery stenosis, but
also to coronary microvascular disease or to factorsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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compressive forces with normal coronary arteries, as it
happens in left ventricular (LV) hypertrophy, dilated or
hypertrophic cardiomyopathy, aortic valve stenosis. Pre-
vious studies have suggested that CFR may be impaired
in individuals with atherosclerotic risk factors (ARFs).
Also aging induces similar effects and it is likely that CFR
might be attenuated in elderly subjects free of coronary
artery stenosis. An age-dependent reduction of CFR has
been previously reported by PET in limited sample size of
healthy volunteers [8,9]. The reduction of CFR can reflect
a reduction in maximal flow with stable resting flow,
stable maximal flow with increase in resting flow or a
combination of reduction in maximal and increase in
resting flow [1]. The primary end-point of the present
study was to elucidate the most likely mechanism for the
known decrease in CFR with age. Our hypothesis was that
age and composite risk factors had differential impact on
resting versus maximal coronary flow velocity.
Methods
Study population
From the EPIC (Echo Persantine International Coopera-
tive Study) databank between August 2003 and June
2008, 694 patients were selected according to the follow-
ing criteria: history of chest discomfort, dipyridamole
echocardiography test (0.84 mg/Kg over 6’) (DET) per-
formed before (within 15 days) coronary angiography;
coronary angiography showing the absence of any degree
of coronary artery stenosis in any major vessel or sec-
ondary branch. Of this initial population, 349 patients
were excluded for previous revascularization procedures,
resting or stress-induced abnormalities or inadequate
echocardiographic image quality during stress preclud-
ing satisfactory imaging of LAD flow. After exclusions,
345 patients (134 women, age = 61.1 ± 13.3 years) repre-
sented the final study group. The indications for coron-
ary angiography were chest discomfort refractory to
therapy (n = 168), abnormal exercise electrocardiogram
(n = 116) or abnormal perfusion scintigraphy (n = 61).
Stress echocardiographic data were collected and ana-
lysed by stress echocardiographers not involved in the
patient care. The diagnosis of arterial hypertension was
defined in accordance with current European Society of
Hypertension - European Society of Cardiology recom-
mendations [10] and/or the need for antihypertensive
drugs. Diagnosis of diabetes mellitus was based on the
American Diabetic Association guidelines [11]. Hyper-
cholesterolemia was defined according to the criteria of
the European guidelines on cardiovascular disease pre-
vention in clinical practice [12]. Cigarette smoking habit
was self-reported. Data of anti-hypertensive and/or anti-
ischemic therapy, if any, at time of testing were collected
for each subject.Subjects gave written informed consent and the study
was approved by the Institutional Ethic Committee.
Procedures
Twelve-hour fasting blood samples were obtained the
same day as standard echocardiographic examination
and CFR assessment. The measurements of lipid and
glucose levels were performed by enzymatic methods
(Boehringer Mannheim).
All the resting and stress echocardiographic examina-
tions were done with commercially available ultrasound
machines (Sequoia C256 Acuson Siemens, Mountain
View, CA; Sonos 5500–7500 Philips Ultrasound,
Andover MA; Vivid System 7, GE, Horten, USA)
equipped with a miltifrequency phased-array sector scan
probe and with harmonic technology. Echocardiographic
examination at rest was recorded in order to obtain left
ventricular (LV) quantitative analysis. LV end-diastolic
and end-systolic volumes were measured by 2-D biplane
method (modified Simpson’s rule) and LV ejection frac-
tion (%) derived [13]. LV mass was calculated according
to the recommended ASE formula and indexed for body
surface area (g/m2) [13]. LV hypertrophy was defined as a
LV mass >95 g/m 2 in women and> 115 g/m2 in men
[13]. Besides the standard views for stress echo testing,
specific views for LAD coronary artery was integrated
into the cardiac imaging sequence. 2-D echocardiography
and 12-lead ECG monitoring were performed in combin-
ation with high-dose dipyridamole (up to 0.84 mg over
6 min), in accordance to well established protocols
[14,15]. During the procedure, BP and ECG were
recorded each minute. Coronary flow in the mid-distal
portion of LAD was searched in the low parasternal long-
axis cross section under the guidance of colour Doppler
flow mapping and attention was taken to maintain a con-
stant incident (theta) angle (< 30°) between coronary flow
and the Doppler beam during the entire duration of the
tests [16]. All studies were digitally stored to simplify off-
line reviewing and measurements. Coronary flow velocity
parameters were analysed off-line by use of the built-in
calculation package of the ultrasound unit. Flow velocities
were measured at least twice for each study: at rest and at
peak stress (before aminophylline injection). At each time
point, three optimal profiles of peak diastolic Doppler
flow velocities were measured, and the results were aver-
aged. Coronary blood flow velocity reserve was defined as
the ratio between hyperemic and resting peak diastolic
coronary flow velocities Quality control of the diagnostic
performance in the different centers was performed as
previously described [17]. The intra- and inter-observer
variability for measurements of Doppler-derived coronary
flow assessment were <10% [18].
Coronary angiography in multiple views was per-
formed according to the standard Judkins or Sones
Table 1 Demographics and main echo characteristics of the study population according to age quartiles
Age< 55 years Age 55–62 years Age 63–69 years Age ≥70 years p
n= 85 n=87 n=85 n=88
Sex (M/F) 53 / 32 53 / 34 52 / 33 53 / 35 NS
Age (years) 42.7 ± 9.4 58.9 ± 2.2 66.4 ± 2.2 75.9 ± 4.4 <0.0001
(40.6-44.7) (58.5-59.4) (65.9-66.9) (74.9-76.8)
BMI (Kg/m2) 25.3 ± 3.6 26.9 ± 3.9 26.8 ± 3.8 26.2 ± 3.9 <0.05
(24.5-26.1) (26.1-27.8) (26.0-27.6) (25.4-27.0)
SBP (mmHg) 131.8 ± 15.7 139.3 ± 16.9 142.8 ± 18.3 146.5 ± 19.1 <0.0001
(128.4-135.2) (135.7-142,9) (138.8-146.7) (142.5-150.6)
DBP (mmHg) 76.9 ± 10.4 81.1 ± 10.6 84.6 ± 9.9 86.1 ± 10.8 <0.0001
(74.7-79.2) (78.9-83.4) (82.4-88.7) (83.8-88.4)
MBP ( mmHg) 95.3 ± 11.2 100.5 ± 11.6 103.9 ± 11.6 106.2 ± 11.9 <0.0001
(92.8-97.7) (98.1-103.0) (101.5-106.5) (103.7-108.7)
HR (bpm) 69.9 ± 8.0 68.6 ± 8.8 71.1 ± 8.6 68.3 ± 8.2 NS
(68.2-71.6) (66.7-70.5) (69.2-72.9) (66.4-70.2)
Total cholesterol (mg/dL) 174.3 ± 27.2 199.8 ± 43.7 202.1 ± 36.6 204.6 ± 41.3 <0.0001
(168.4-180.2) (190.5-209.1) (192.2-208.1) (195.9-213.4)
Fasting blood glucose (mg/dL) 98.0 ± 19.9 102.4 ± 25.9 101.5 ± 24.9 99.5 ± 22.1 NS
(93.7-102.3) (96.9-107.9) (96.1-106.9) (94.8-104.1)
EF (%) 60.4 ± 6.0 61.6 ± 5.6 60.8 ± 6.3 60.6 ± 5.6 NS
(59.1-61.7) (60.4-62.7) (59.4-62.2) (59.4-61.8)
LVMi (g/m2) 97.7 ± 23.6 112.4 ± 28.7 110.3 ± 22.0 115.8 ± 24.7 <0.0001
(92.6-102.8) (106.3-118.5) (105.6-115.1) (110.5-121.0)
Cardiac therapy (%, n) 20.0% (17) 47.1% (41) 54.1% (46) 59.1% (52) <0.0001
Data expressed as mean ± SD (95% confidence interval for mean) or as percentage.
BMI = Body mass index, DBP=Diastolic blood pressure, EF = Ejection fraction, HR =Heart rate, MBP=Mean blood pressure, SBP = Systolic BP, LVMi = Left ventricular
mass index.
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views) were acquired for the left and at least two orthog-
onal views for the right coronary arteries, respectively.
Additional appropriate projections were obtained in case
of superimposition of side branches or foreshortening of
the segment of interest. Two independent, blinded
observers reviewed each angiogram. In case of disagree-
ment (10% of cases), a third observer reviewed the
exams and the judgment was binding.
Statistical analysis
Statistical analyses were performed by SPSS package, re-
lease 12 (SPSS Inc, Chicago, Illinois, USA) Data are pre-
sented as mean value ± SD. Descriptive statistics wasTable 2 Atherosclerotic risk factors of the study population a
Factor Age< 55 years Age 55–62 year
Cigarette smoking 22.3% (19/85) 25.3% (22/87)
Arterial hypertension 24.7% (21/85) 63.2% (55/87)
Diabetes mellitus 17.6% (15/85) 19.5% (17/87)
Hypercholesterolemia 12.9% (11/85) 55.2% (48/87)
Data are expressed as percentage (number of patients with ARF / total number forobtained by one-factor ANOVA and χ2 distribution with
computation of exact p value by Monte Carlo method.
Least squares linear regression was used to evaluate uni-
variate and multivariate correlates of CFR measurements.
For multiple linear regression model, multicollinearity
was also examined by computation of in-model toler-
ance. The null hypothesis was rejected for p value< 0.05.
Results
The study population was divided into quartiles of age:
1st quartile =< 55 years, 2nd quartile = ≥ 55 and 62 years,
3rd quartile = between ≥ 63 years and 69 years, 4th quar-
tile =≥ 70 years. Table 1 reports the clinical characteris-
tics and main echocardiographic parameters accordingccording to age quartiles
s Age 63–69 years Age ≥70 years P
24.7% (21/85) 25.0% (22/88) NS
64.7% (55/85) 65.9% (58/88) <0.01
22.4% (19/85) 21.6% (19/88) <0.05
60.0% (51/85) 57.9% (51/88) <0.01
age quartile).
Table 3 Coronary flow reserve test according to age quartiles
Age< 55 years Age 55–62 years Age 63–69 years Age≥ 70 yrs p
CFR 3.01 ± 0.69 (2.87-3.16) 2.67 ± 0.54 (2.56-2.79) 2.47 ± 0.54 (2.36-2.59) 2.39 ± 0.49 (2.28-2.49) <0.0001
CFV at rest (cm/s) 26.3 ± 6.1 (25.0-27.6) 28.7 ± 8.9 (26.8-30.7) 30.8 ± 8.8 (28.8-32.9) 30.2 ± 6.4 (28.6-31.5) <0.001
CFV after Dip (cm/s) 77.7 ± 18.9 (73.5-82.0) 75.4 ± 22.9 (70.6-80.1) 74.6 ± 21.4 (69.9-79.1) 70.9 ± 18.4 (66.9-74.6) NS
Data expressed as mean ± SD (95% confidence interval for mean).
CFR = Coronary flow reserve, CFV =Coronary flow velocity.
Figure 1 Upper panel: Correlation between age and Doppler
velocities at rest. Lower panel: Correlation between age and
Doppler velocities at hyperemic flow. Resting velocities progressively
decrease with age, whereas hyperemic flow velocities remain
unaffected.
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increased significantly with age. Heart rate was not sig-
nificantly different among the various age groups. LV
mass index significantly increasedwith aging. The preva-
lence of LV hypertrophy in the pooled population was
44% (150/345). The frequency of anti-hypertensive and/
or anti-ischemic therapy at time of testing (not discon-
tinued) was significantly higher in the 4th quartile
(p< 0.0001). Table 2 reports the prevalence of the main
ARFs for age quartiles. Arterial hypertension had the
greatest prevalence in the pooled population (54.8%),
followed by hypercholesterolemia (46.7%), smoking habit
(24.3%) and diabetes (20.3%) The frequency of arterial
hypertension, hypercholesterolemia and, with a lower
extent, diabetes mellitus increased with aging.
Table 3 summarizes the data of the CFR test according
to age quartiles. Mean CFR was 2.63 ± 0.71. In the whole
population CFR was gradually reduced with increasing
age, showing the lowest value in the fourth quartile of
age (p< 0.0001). This reduction was accounted for an
increase of resting coronary flow velocities while the
hyperemic coronary flow velocities remained unaffected
in the several age classes (p = 0.08, NS).
We also analysed the data excluding the 116 patients
with objective signs of ischemia at study entry (by ECG
criteria and/or perfusion abnormalities) in order to rule
out microvascular angina as a potential confounder. In
the subset of 219 patients with no objective signs of is-
chemia, CFR was also gradually reduced with increasing
age (p< 0.001).
In the pooled population age was correlated positively
with coronary flow velocity at rest (r = 0.20, p< 0.0001)
and negatively with hyperemic coronary flow velocity
(r =−0.13, p< 0.02) (Figure 1). Age was negatively corre-
lated with CFR (r =−0.41, p< 0.0001) (Figure 2) and was
also related with systolic BP (r = 0.34), diastolic BP
(r = 0.37) and mean BP (r = 0.39) (all p< 0.0001), with
total blood cholesterol (r = 0.27) (p< 0.0001), fasting
blood glucose (r = 0.18) (p< 0.001), body mass index
(r = 0.12, p = 0.03) and LV mass index (r = 0.43,
p< 0.0001).
A multiple linear regression analysis was performed to
identify the independent associations of CFR, by includ-
ing continuous variables (body mass index, heart rate,
diastolic BP, total blood cholesterol, fasting blood glu-
cose, LV mass index), categorical variables (male gender,cigarette smoking) and age quartiles as potential contri-
butors (Table 4). CFR was independently associated with
both the third (standardized β coefficient =−0.16, p
< 0.005) and fourth (β=−0.22, p< 0.0001) age quartile.
Among ARFs, elevated diastolic BP (p< 0.001) and high
total cholesterol (p< 0.002) showed the best independ-
ent associations with CFR reduction, while the contri-
bution of fasting blood glucose was lower (p< 0.01) and
that of cigarette smoking did not achieve the statist-
ical significance (p = 0.06). LVM index was a strong
determinant of CFR (β=−0.32, p< 0.0001). Of note, by
analyzing the impact of ARFs on hyperemic coron-
ary flow velocity after adjusting for the same confoun-
ders analyzed in Table 4, only total blood cholesterol
Figure 2 Correlation between CFR and age. CFR decreases
progressively with aging.
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(β=−0.134) and LV mass index (β=−0.130) (all p< 0.02)
were independently associated with the hyperemic coron-
ary flow velocity.
Discussion
The present study demonstrates that the impact of aging
on TTE-CFR in patients with angiographically normal
coronary arteries is primarily due to the increase of cor-
onary flow velocity at rest. Also ARFs and increased LV
mass are associated with reduced CFR.
The influence of aging on CFR has been previously
assessed using PET, in populations of limited size,
which included healthy volunteers and not patients with
ARFs [8,9]. In the first of these studies, by using 13 N-
ammonia in 40 healthy volunteers, Czernin et al [8]Table 4 Multiple independent correlates of CFR variables




Age quartile 2 −0.07 −2.01 0.201
Age quartile 3 −0.16 −2.77 <0.005
Age quartile 4 −0.22 −3.60 <0.0001
Male sex −0.10 −2.08 <0.05
BMI −0.03 −0.71 0.481
HR −0.10 −2.23 <0.05
DBP −0.17 −3.44 <0.001
Total cholesterol −0.15 −3.06 <0.002
Fasting blood glucose −0.12 −2.62 <0.01
Cigarette smoking −0.08 −1.92 0.056
LVMi −0.32 −6.66 <0.0001
Constant 15.44 <0.0001
Cumulative R2 = 0.350, SE = 0.50, p< 0.00001.
The age reference is the youngest quartile (18–54 years).
Abbreviations as in Table 1.demonstrated that aging did not alter significantly dipyr-
idamole-induced myocardial hyperemic flow and that
the gradual decline of myocardial blood flow reserve
correlated with an age-related increase of myocardial
work and blood flow at rest. In the other study, which
used 16O-water PET on 56 normal volunteers, myocar-
dial blood flow at rest and after hyperemia were roughly
comparable up to 60 years of age, there was a significant
increase in resting flow above 60 years and a significant
reduction in hyperemic flow only above 70 years [9].
The present study extends these findings and is the
first to analyze the impact of aging on CFR derived by
TTE, in a multicenter large population of patients with
ARFs in which the presence of any degree of coronary
artery stenosis was excluded on the basis of coronary
angiography. Aging reduces CFR and the impact of this
impairment is increased as the number of ARFs
increases. In this view, the mean values of CFR observed
in each age quartiles cannot be assumed as normal refer-
ence values but reflect the cumulative impact of ARFs
and of LV mass on coronary microcirculation, without
the hemodynamic burden of coronary artery stenosis.
The adverse influence of arterial hypertension, diabetes
mellitus, hypercholesterolemia, cigarette smoking and
LV hypertrophy on coronary microcirculation is well
known [19-31]. It is worthy of note that in the present
study total blood cholesterol, diastolic BP and LV mass
index were independently associated to the reduction of
hyperemic coronary velocity, true expression of impaired
coronary microcirculation when epicardial coronary
arteries are normal. Our results are also consistent with
findings of Ahmari et al [32] who have demonstrated on
59 patients that traditional risk factors are related to a
lower CFR in the face of a negative dobutamine stress
echocardiography for wall motion criteria.. In the
present study we evaluated intermediate risk patients
with chest pain and/or positive test of inducible ischemia
but totally normal coronary arteries at coronary angiog-
raphy. In a recent study from our group [33], we
assessed the prognostic impact of CFR in patients with
normal or near-normal coronary arteries, identifying a
subset of patients at higher risk of events when CFR was
impaired. However, near–normal coronary arteries in-
clude subjects with subcritical lesions that may become
troublemakers in the long-run, and at higher risk on the
basis of coronary anatomy per se due to calcifications or
soft plaques more prone to instability [34]. In this view,
patients with near-normal coronary arteries were
excluded from the present study, which included only 10
patients (3%) of the previous report [33].
Study limitations
The study has some technical limitations corresponding
to Doppler assessment of CFR. The main limitation is
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surrogate of flow reserve. Flow within the coronary ar-
tery cannot be calculated by transthoracic echocardiog-
raphy because cross-sectional visualization of the vessel
does not allow an accurate measurement of the diameter
of the vessel. However, the estimated CFR can be con-
sidered accurate if the coronary functions only as a con-
duit, without changing in diameter during drug infusion.
This assumption is reasonable by using vasodilating
stressors such as adenosine and dipyridamole [35]. An-
other potential limitation corresponds to the determin-
ation of absolute coronary flow velocity which can be
affected in some patients by the large incident (theta)
angle between the blood flow velocity pattern and the
Doppler beam. However, a< 30° angle theta was main-
tained constant for all the duration of the tests in the
present study, without variation between resting and
hyperemic conditions.
In conclusion, the age-related effect on coronary flow
reserve is mainly due to the progressive increase of rest-
ing coronary flow velocity at rest. Coronary flow reserve
is impaired also by the combined action of atheroscler-
otic risk factors and by the additional effect of increased
LV mass. The present results have important clinical
implications since demonstrate the cumulative effect of
aging and traditional atherosclerotic risk factors on cor-
onary flow reserve in the absence of demonstrable epi-
cardial coronary artery disease. Aging is not modifiable
but its effect should be taken into account when weigh-
ing its clinical role with other factors affecting coronary
microvascular function, especially for the values of CFR
ranging between 2 and 3. Standards of normality for
CFR should be normalized for age, as it is the case for
other echocardiographic parameters, such as wall thick-
ness or Doppler-derived diastolic measurements and
pulmonary arterial systolic pressure.
Competing interest
The authors declare that they have no competing interests.
Acknowledgment
Sabrina Molinaro, BSc, revised the statistical methodology of the manuscript.
Author details
1Division of Cardioangiology, Department of Clinical and Experimental
Medicine, Federico II University Hospital, Naples, Italy. 2Division of Cardiology,
“Dell’Angelo” Hospital, Mestre, Italy. 3Division of Cardiology, Bufalini Hospital,
Cesena, Italy. 4Division of Cardiology, Lucca Hospital, Lucca, Italy. 5Institute of
Clinical Physiology, National Council of Research, Pisa, Italy. 6Department of
Clinical and Experimental Medicine, Echo Lab, Cardioangiology Unit, Edificio
1, Federico II University Hospital, Via S. Pansini 5, Naples 80131, Italy.
Authors contribution
MG conceived of the study and participated in its design and coordination,
performed the statistical analysis and drafted the manuscript, FR, SG and LC
participated in the study design and coordination and performed echo
scans, CS participated in the study coordination and performed echo scans,
RS and EP participated in the study design, performed and revised thestatistical analysis and revised the manuscript. All authors read and approved
the final manuscript.
Received: 21 April 2012 Accepted: 14 May 2012
Published: 14 May 2012References
1. Hoffman JIE: Maximal coronary flow and the concept of coronary flow
reserve. Circulation 1984, 70:153–159.
2. Hoffmann JIE: Transmural myocardial perfusion. Progr Cardiovasc Dis 1987,
24:429–464.
3. Gould LK, Lipscomb K, Hamilton GW: Physiologic basis for assessing
critical coronary stenosis. Instantaneous flow response and regional
distribution during coronary hyperemia as measures of coronary flow
reserve. Am J Cardiol 1974, 33:87–94.
4. Gould LK, Lipscomb K: Effects of coronary stenosis on coronary flow
reserve and resistance. Am J Cardiol 1974, 34:48–55.
5. Vassalli G, Hess OM: Measurement of coronary flow reserve and its role in
patient care. Basic Res Cardiol 1998, 93:339–353.
6. Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T, Morioka S:
Noninvasive assessment of significant left anterior descending coronary
artery stenosis by coronary flow velocity reserve with transthoracic color
Doppler echocardiography. Circulation 1998, 97:1557–1562.
7. Caiati C, Zedda N, Montaldo C, Bina A, Iliceto S: Contrast-enhanced
transthoracic second harmonic echo Doppler with adenosine: a non
invasive, rapid and effective method for coronary flow reserve
assessment. J Am Coll Cardiol 1999, 34:122–130.
8. Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K,
Chan A, Phelps ME, Schelbert HR: Influence of age and hemodynamics on
myocardial blood flow and flow reserve. Circulation 1993, 88:62–69.
9. Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, Olivotto I,
Rosen SD, Impallomeni M, Wijns W: Effect of aging on myocardial
perfusion reserve. J Nucl Med 1995, 36:2032–2036.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G,
Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L,
Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J,
De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C,
Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M,
Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni
E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E,
Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM,
Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F,
Tamargo J, van Zwieten P, Waeber B, Williams B, ESH-ESC Task Force
on the Management of Arterial Hypertension: ESH-ESC practice guidelines
for the management of arterial hypertension: ESH-ESC Task force
on the management of arterial hypertension. J Hypertens 2007,
25:1751–1762.
11. American Diabetes Association: Diagnosis and classification of diabetes
mellitus. Diabetes Care 2004, 27(SI):S5–S10.
12. Fourth Joint Task Force of the European Society of Cardiology and Other
Societies on Cardiovascular Disease Prevention in Clinical Practice:
European guidelines on cardiovascular disease prevention in clinical
practice: executive summary. Eur Heart J 2007, 28:2375–2414.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA,
Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT,
Sutton MS, Stewart WJ, Task Force on Chamber Quantification; American
College of Cardiology Echocardiography Committee, American Heart
Association; European Association of Echocardiography, European Society of
Cardiology, European Society of Cardiology, Chamber Quantification Writing
Group, American Society of Echocardiography's Guidelines and Standards
Committee, European Association of Echocardiography: Recommendations
for chamber quantification: a report from the American Society of
Echocardiography's Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction with
the European Association of Echocardiography, a branch of the
European Society of Cardiology. Eur J Echocardiogr 2006, 7:79–108.
14. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG, for American
Society of Echocardiography: American Society of Echocardiography
recommendations for performance, interpretation, and application of
stress echocardiography. J Am Soc Echocardiogr 2007, 20:1021–1041.
Galderisi et al. Cardiovascular Ultrasound 2012, 10:20 Page 7 of 7
http://www.cardiovascularultrasound.com/content/10/1/2015. Dal Porto R, Faletra F, Picano E, Pirelli S, Moreo A, Varga A: Safety,
feasibility, and diagnostic accuracy of accelerated high-dose
dipyridamole stress echocardiography. Am J Cardiol 2001, 87:520–524.
16. Rigo F: Coronary flow reserve in stress-echo lab. From pathophysiologic
toy to diagnostic tool. Cardiovasc Ultrasound 2005, 3:8.
17. Rigo F, Gherardi S, Galderisi M, Pratali L, Cortigiani L, Sicari R, Picano E: The
prognostic impact of coronary flow-reserve assessed by Doppler
echocardiography in non-ischaemic dilated cardiomyopathy. Eur Heart J
2006, 27:1319–1323.
18. Rigo F, Sicari R, Gherardi S, Djordjevic-Dikic A, Cortigiani L, Picano E: The
additive prognostic value of wall motion abnormalities and coronary
flow reserve during dipyridamole stress echo. Eur Heart J 2008, 29:79–88.
19. Bartel T, Yang Y, Müller S, Wenzel RR, Baumgart D, Philipp T, Erbel R:
Noninvasive assessment of microvascular function in arterial
hypertension by transthoracic Doppler harmonic echocardiography. J
Am Coll Cardiol 2002, 39:2012–2018.
20. Struijker Boudier HA, Cohuet GM, Baumann M, Safar ME: The heart,
macrocirculation and microcirculation in hypertension: a unifying
hypothesis. J Hypertens 2003, 21:S19–S23.
21. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H, Muderrisoglu H:
Effects of normal blood pressure, pre-hypertension and hypertension on
coronary microvascular function. Circulation 2007, 115:593–599.
22. Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH,
Sayre JW, Hsueh WA, Schelbert HR: Coronary circulatory dysfunction in
insulin resistance, impaired glucose tolerance, and type 2 diabetes
mellitus. Circulation 2005, 111:2291–2298.
23. Galderisi M: Diastolic dysfunction and diabetic cardiomyopathy:
evaluation by Doppler echocardiography. J Am Coll Cardiol 2006,
48:1548–1551.
24. Galderisi M, de Simone G, Cicala S, Parisi M, D'Errico A, Innelli P, de Divitiis
M, Mondillo S, de Divitiis O: Coronary flow reserve in hypertensive
patients with hypercholesterolemia and without coronary heart disease.
Am J Hypertens 2007, 20:177–183.
25. Yokoyama I, Ohtake T, Momamura SI, Nishikawa J, Sasaki Y, Omata M:
Reduced coronary flow reserve in hypercholesterolemic patients without
overt coronary artery disease. Circulation 1996, 94:3232–3238.
26. Zeiher AM, Schachinger V, Minners J: Long-term cigarette smoking impairs
endothelium dependent coronary arterial vasodilator function. Circulation
1995, 92:1094–1100.
27. Ashikaga T, Nishizaki M, Fujii H, Niki S, Maeda S, Yamawake N, Kishi Y, Isobe
M: Examination of the microcirculation damage in smokers versus
nonsmokers with vasospastic angina pectoris. Am J Cardiol 2007,
100:962–964.
28. Strauer BE, Schwartzkopff B: Objectives of high blood pressure treatment:
left ventricular hypertrophy, diastolic function, and coronary reserve. Am
Hypertens 1998, 11:879–881.
29. Kozakova M, Galetta F, Gregorini L, Bigalli G, Franzoni F, Giusti C, Palombo C:
Coronary vasodilator capacity and epicardial vessel remodeling in
physiological and hypertensive hypertrophy. Hypertension 2000, 36:343–
349.
30. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR jr, Lerman A:
Attenuated coronary flow reserve and vascular remodeling in patients
with hypertension and left ventricular hypertrophy. J Am Coll Cardiol
2000, 35:1654–1660.
31. Galderisi M, Capaldo B, Sidiropulos, D'Errico A, Ferrara L, Turco A, Guarini P,
Riccardi G, de Divitiis O: Determinants of reduction of coronary flow
reserve in patients with type 2 diabetes mellitus or arterial hypertension
without angiographically determined epicardial coronary stenosis. Am J
Hypertens 2007, 20:1283–1290.
32. Ahmari SA, Bunch TJ, Modesto K, Stussy V, Dichak A, Seward JB, Pellikka PA,
Chandrasekaran K: Impact of individual and cumulative coronary flow
reserve ossesse by dobutamine stres echocardiography. Am J Cardiol
2008, 101:1694–1699.
33. Sicari R, Rigo F, Gherardi S, Gherardi S, Galderisi M, Picano E: Additive
prognostic value of coronary flow reserve in patients with chest pain
syndrome and normal or near-normal coronary arteries. Am J Cardiol
2009, 103:626–631.
34. Caussin C, Ohanessian A, Lancelin B, Rahal S, Hennequin R, Dambrin G,
Brenot P, Angel CY, Paul JF: Coronary plaque burden detected by
multislice computed tomography after acute myocardial infarction withnear-normal coronary arteries by angiography. Am J Cardiol 2003,
92:849.852.
35. Sudhir K, MacGregor JS, Barbant SD, Barbant SD, Foster E, Fitzgerald PJ,
Chatterjee K, Yock PG: Assessment of coronary conductance and resistance
vessel reactivity in response to nitroglycerin, ergonovine and adenosine:
in vivo studies with simultaneous intravascular two-dimensional and
Doppler ultrasound. J Am Coll Cardiol 1993, 21:1261–1268.
doi:10.1186/1476-7120-10-20
Cite this article as: Galderisi et al.: The impact of aging and
atherosclerotic risk factors on transthoracic coronary flow reserve
in subjects with normal coronary angiography. Cardiovascular Ultrasound
2012 10:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
